| Original language | English |
|---|---|
| Pages (from-to) | e86-e88 |
| Journal | Haemophilia |
| Volume | 28 |
| Issue number | 3 |
| Early online date | 2022 |
| DOIs |
|
| Publication status | Published - May 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Haemophilia, Vol. 28, No. 3, 05.2022, p. e86-e88.
Research output: Contribution to journal › Comment/Letter to the editor › Academic
TY - JOUR
T1 - Gene therapy of hemophilia
T2 - Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC
AU - Miesbach, Wolfgang
AU - Baghaei, Fariba
AU - Boban, Ana
AU - Chowdary, Pratima
AU - Coppens, Michiel
AU - Hart, Daniel P.
AU - Jimenez-Yuste, Victor
AU - Klamroth, Robert
AU - Makris, Mike
AU - Noone, Declan
AU - Peyvandi, Flora
N1 - Funding Information: Wolfgang Miesbach: Bayer, Biomarin, Biotest, CSL Behring, Chugai, Freeline, LFB, Novo Nordisk, Octapharma, Pfizer, Roche, Sanofi, Takeda/Shire, uniQure. Ana Boban: Bayer, CSL Behring, Novo Nordisk, Octapharma, Pfizer, Roche, Sobi, Takeda. Fariba Baghaei: Bayer, Octapharma, Pfizer, Novo Nordisk, Shire/Takeda, Roche, BioMarin, uniQure, Sobi. Pratima Chowdary: advisory boards for Bayer, Boehringer Ingelheim, CSL Behring, Chugai, Freeline, NovoNordisk, Pfizer, Roche, Sanofi, Spark, Sobi and Takeda; and has received research funding from Bayer, CSL Behring, Freeline, Novo Nordisk, Pfizer, SOBI and Takeda. Michiel Coppens: Research support: Bayer, CSL Behring, Roche, Sanquin Blood Supply, UniQure; Consultancy or lecturing fees: Bayer, CSL Behring, Medcon International, MEDtalks, NovoNordisk, Pfizer, Sobi. Daniel P. Hart: Bayer, Biomarin, Biotest, CSL Behring, Grifols, NovoNordisk, Octapharma, Pfizer, Roche, Sanofi, Sobi, Spark, Takeda, UniQure. Victor Jimenez‐Yuste: Bayer, Biomarin, CSL Behring, Novo Nordisk, Octapharma, Pfizer, Roche, Sanofi, Takeda/Shire. Robert Klamroth: Research Funding and Consultancy: Bayer, Biomarin, Biotest, CSL Behring, Novo Nordisk, Octapharma, Pfizer, Roche/Chugai, Sanofi, SOBI, Takeda/Shire, uniQure. Mike Makris participated in advisory boards run by Freeline, Spark Therapeutics and NovoNordisk. Flora Peyvandi: speaker at educational symposia organized by Roche, Sanofi, Sobi, Takeda. Member of Advisory Board of Roche, Sanofi, Sobi, Takeda.
PY - 2022/5
Y1 - 2022/5
UR - http://www.scopus.com/inward/record.url?scp=85125884512&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/hae.14546
DO - https://doi.org/10.1111/hae.14546
M3 - Comment/Letter to the editor
C2 - 35263819
SN - 1351-8216
VL - 28
SP - e86-e88
JO - Haemophilia
JF - Haemophilia
IS - 3
ER -